IPO参考
08-06
【荣昌生物:预计上半年归母净利润约47亿元,同比扭亏】
荣昌生物8月5日公告,预计2026年上半年实现营业收入约58.5亿元,同比增加约433;归母净利润约47亿元,上年同期亏损4.5亿元。该公司称,报告期内业绩变化的主要原因是公司核心产品泰它西普、维迪西妥单抗国内销售收入持续增长。(界面新闻)
$荣昌生物(688331)$
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":593778899657232,"tweetId":"593778899657232","gmtCreate":1785982235393,"gmtModify":1785982238268,"author":{"id":4094609998215480,"idStr":"4094609998215480","authorId":4094609998215480,"authorIdStr":"4094609998215480","name":"IPO参考","avatar":"https://static.tigerbbs.com/04c6c3977d5800ba96209755de92be5a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":549,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body>【荣昌生物:预计上半年归母净利润约47亿元,同比扭亏】\n<br>\n荣昌生物8月5日公告,预计2026年上半年实现营业收入约58.5亿元,同比增加约433;归母净利润约47亿元,上年同期亏损4.5亿元。该公司称,报告期内业绩变化的主要原因是公司核心产品泰它西普、维迪西妥单抗国内销售收入持续增长。(界面新闻) <a href=\"https://laohu8.com/S/688331\">$荣昌生物(688331)$</a></body></html>","htmlText":"<html><head></head><body>【荣昌生物:预计上半年归母净利润约47亿元,同比扭亏】\n<br>\n荣昌生物8月5日公告,预计2026年上半年实现营业收入约58.5亿元,同比增加约433;归母净利润约47亿元,上年同期亏损4.5亿元。该公司称,报告期内业绩变化的主要原因是公司核心产品泰它西普、维迪西妥单抗国内销售收入持续增长。(界面新闻) <a href=\"https://laohu8.com/S/688331\">$荣昌生物(688331)$</a></body></html>","text":"【荣昌生物:预计上半年归母净利润约47亿元,同比扭亏】 荣昌生物8月5日公告,预计2026年上半年实现营业收入约58.5亿元,同比增加约433;归母净利润约47亿元,上年同期亏损4.5亿元。该公司称,报告期内业绩变化的主要原因是公司核心产品泰它西普、维迪西妥单抗国内销售收入持续增长。(界面新闻) $荣昌生物(688331)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/593778899657232","repostId":0,"isVote":1,"tweetType":1,"viewCount":712,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["688331","09995"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":278,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/593778899657232"}
精彩评论